The efficacy of oligonucleotide chip detecting YMDD mutants of hepatitis B virus in lamivudine-treated patients.

被引：0
|
作者：
Heo, J
Cho, M
Kim, GH
Kang, DH
Song, GA
Yang, US
Jang, HJ
Park, HK
Kim, CM
Kim, HH
Cho, BM
Shin, WW
机构：
[1] Pusan Natl Univ, Coll Med, Pusan, South Korea
[2] Pusan Natl Univ, Coll Nat Sci, Pusan, South Korea
[3] Donga Univ, Coll Med, Pusan, South Korea
来源：
HEPATOLOGY | 2003年 / 38卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1163
引用
收藏
页码：716A / 717A
页数：2
相关论文
共 50 条
  • [21] Characteristic features among YMDD motif mutants of hepatitis B virus: Replication and lamivudine resistance.
    OnoNita, SK
    Kato, N
    Shiratori, Y
    Omata, M
    HEPATOLOGY, 1997, 26 (04) : 1210 - 1210
  • [22] Viral quasispecies of hepatitis B virus in patients with YMDD mutation and lamivudine resistance may not predict the efficacy of lamivudine/adefovir rescue therapy
    Wang, Changtai
    Yu, Shu
    Zhang, Yafei
    Zhang, Min
    Lv, Liying
    Huang, Cheng
    Li, Xu
    Li, Jun
    Zhang, Zhenhua
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 17 (04) : 2473 - 2484
  • [23] The efficacy of lamivudine treatment of chronic hepatitis B in Thai patients.
    Hongsirinirachorn, M
    Chutaputti, A
    GASTROENTEROLOGY, 2000, 118 (04) : A1448 - A1448
  • [24] Subclones of drug-resistant hepatitis B virus mutants and the outcome of breakthrough hepatitis in patients treated with lamivudine
    Kumashiro, R
    Kuwahara, R
    Ide, T
    Koga, Y
    Arinaga, T
    Hisamochi, A
    Ogata, K
    Tanaka, K
    Sata, M
    INTERVIROLOGY, 2003, 46 (06) : 350 - 354
  • [25] Clearance of the original hepatitis B virus YMDD-motif mutants with emergence of distinct lamivudine-resistant mutants during prolonged lamivudine therapy
    Yeh, CT
    Chien, RN
    Chu, CM
    Liaw, YF
    HEPATOLOGY, 2000, 31 (06) : 1318 - 1326
  • [26] Rapid quantitation of lamivudine-resistant mutants in lamivudine treated and untreated patients with chronic hepatitis B virus infection
    Shi, Ming
    Yang, Zhi-Jun
    Wang, Rong-Sheng
    Zhang, Hua
    Zhu, Ya-Fen
    Xu, Yong-Ping
    Lin, Qiu-Ye
    Jin, Li-Ji
    CLINICA CHIMICA ACTA, 2006, 373 (1-2) : 172 - 175
  • [27] Emergence of hepatitis B virus resistant to lamivudine in immunocompetent patients.
    Fujioka, S
    Shimomura, H
    Fujio, K
    Ikeda, F
    Miyake, M
    Tsuji, T
    HEPATOLOGY, 1997, 26 (04) : 1524 - 1524
  • [28] Low rate of YMDD motif mutations in polymerase gene of hepatitis B virus in chronically infected patients not treated with lamivudine
    Marie Matsuda
    Fumitaka Suzuki
    Yoshiyuki Suzuki
    Akihito Tsubota
    Norio Akuta
    Tetsuya Hosaka
    Takashi Someya
    Masahiro Kobayashi
    Satoshi Saitoh
    Yasuji Arase
    Junko Satoh
    Kimiko Takagi
    Mariko Kobayashi
    Kenji Ikeda
    Hiromitsu Kumada
    Journal of Gastroenterology, 2004, 39 : 34 - 40
  • [29] Low rate of YMDD motif mutations in polymerase gene of hepatitis B virus in chronically infected patients not treated with lamivudine
    Matsuda, M
    Suzuki, F
    Suzuki, Y
    Tsubota, A
    Akuta, N
    Hosaka, T
    Someya, T
    Kobayashi, M
    Saitoh, S
    Arase, Y
    Satoh, J
    Takagi, K
    Kobayashi, M
    Ikeda, K
    Kumada, H
    JOURNAL OF GASTROENTEROLOGY, 2004, 39 (01) : 34 - 40
  • [30] Is it safe to stop lamivudine after the emergence of YMDD mutants during lamivudine therapy for chronic hepatitis B?
    Wong, VWS
    Chan, HLY
    Wong, ML
    Leung, N
    JOURNAL OF HEPATOLOGY, 2002, 36 : 177 - 177
12345